Khoi Chu
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Bone health and treatments
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 13
- Cancer Cells and Metastasis 5
- Bone health and treatments 4
- HER2/EGFR in Cancer Research 3
-
- Wnt/β-catenin signaling in development and cancer 4
- Co-authors
- Fredika M. Robertson (7 shared papers)Li‐Yuan Yu‐Lee (6 shared papers)Sue-Hwa Lin (5 shared papers)Christopher J. Logothetis (5 shared papers)Yu-Chen Lee (4 shared papers)Xiangcang Ye (4 shared papers)Sanford H. Barsky (4 shared papers)Ricardo Moraes (3 shared papers)
- Journals
- Cancer Research (4 papers)Oncotarget (3 papers)Journal of Nanobiotechnology (2 papers)Breast Cancer Research and Treatment (2 papers)SpringerPlus (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Khoi Chu
20 papers receiving 858 citations
Peers
Comparison fields: 5 of 72
- Oncology 468
- Cancer Research 188
- Immunology and Allergy 52
- Pulmonary and Respiratory Medicine 218
- Molecular Biology 432
Countries citing papers authored by Khoi Chu
This map shows the geographic impact of Khoi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khoi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khoi Chu more than expected).
Fields of papers citing papers by Khoi Chu
This network shows the impact of papers produced by Khoi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khoi Chu. The network helps show where Khoi Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Khoi Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 149 | |
| 2 | 2010 | 101 | |
| 3 | 2016 | 75 | |
| 4 | 2017 | 70 | |
| 5 | 2013 | 65 | |
| 6 | 2013 | 64 | |
| 7 | 2007 | 55 | |
| 8 | 2015 | 51 | |
| 9 | 2010 | 50 | |
| 10 | The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis. | 2013 | 42 |
| 11 | 2013 | 40 | |
| 12 | 2010 | 33 | |
| 13 | 2011 | 25 | |
| 14 | 2012 | 21 | |
| 15 | 2008 | 15 | |
| 16 | 2025 | 4 | |
| 17 | 2011 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2012 | 2 |
About Khoi Chu
Khoi Chu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Biomedical Engineering, having authored 22 papers that have together received 869 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Nanoplatforms for cancer theranostics (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Bone health and treatments (4 papers), HER2/EGFR in Cancer Research (3 papers), Prostate Cancer Treatment and Research (3 papers), Cancer Research and Treatments (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Oncology (468 citations), Cancer Research (188 citations), Immunology and Allergy (52 citations), Pulmonary and Respiratory Medicine (218 citations) and Molecular Biology (432 citations). Khoi Chu has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Fredika M. Robertson, Li‐Yuan Yu‐Lee, Sue-Hwa Lin, Christopher J. Logothetis, Yu-Chen Lee, Xiangcang Ye, Sanford H. Barsky, Ricardo Moraes, Chien-Jui Cheng and Massimo Cristofanilli. Their work appears in journals such as Cancer Research, Oncotarget, Journal of Nanobiotechnology, Breast Cancer Research and Treatment and SpringerPlus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.